Releases: monarch-initiative/mondo
Releases · monarch-initiative/mondo
v2022-12-01
Overview:
- Number of new terms: 160
- Number of changed labels: 29
- Number of changed definitions: 25
- Number obsoleted terms: 3
- Number of new obsoletion candidates: 7
- Number of terms who were previously candidate for obsoletion and are now not anymore: 11
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0029465 | intellectual developmental disorder, autosomal dominant 69 | |
MONDO:0030805 | spinocerebellar ataxia 49 | |
MONDO:0030957 | developmental and epileptic encephalopathy 103 | |
MONDO:0030958 | dystonia 35, childhood-onset | |
MONDO:0030964 | intellectual developmental disorder, autosomal dominant 67 | |
MONDO:0030968 | intellectual developmental disorder, autosomal recessive 76 | |
MONDO:0030969 | intellectual developmental disorder, autosomal dominant 68 | |
MONDO:0030970 | immunodeficiency 106, susceptibility to viral infections | |
MONDO:0030972 | spermatogenic failure 74 | |
MONDO:0030975 | premature ovarian failure 20 | |
MONDO:0030983 | Waardenburg syndrome, IIa 2F | |
MONDO:0030984 | spermatogenic failure 75 | |
MONDO:0030993 | Tessadori-Van Haaften neurodevelopmental syndrome 3 | |
MONDO:0031000 | Tessadori-Van Haaften neurodevelopmental syndrome 4 | |
MONDO:0031019 | spastic paraplegia 87, autosomal recessive | |
MONDO:0031021 | developmental and epileptic encephalopathy 104 | |
MONDO:0031028 | developmental and epileptic encephalopathy 105 with hypopituitarism | |
MONDO:0031030 | immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection | |
MONDO:0031031 | intellectual developmental disorder, autosomal recessive 77 | |
MONDO:0031040 | cholestasis, progressive familial intrahepatic, 12 | |
MONDO:0031043 | lymphatic malformation 12 | |
MONDO:0031044 | advance sleep phase syndrome, familial, 4 | |
MONDO:0031045 | arthrogryposis, distal, IIa 11 | |
MONDO:0031047 | stickler syndrome, IIa 6 | |
MONDO:0031052 | developmental and epileptic encephalopathy 106 | |
MONDO:0031054 | ciliary dyskinesia, primary, 48, without situs inversus | |
MONDO:0031055 | developmental and epileptic encephalopathy 107 | |
MONDO:0031057 | dyskeratosis congenita, digenic | |
MONDO:0031060 | microcephaly 29, primary, autosomal recessive | |
MONDO:0031061 | nephrotic syndrome, IIa 26 | |
MONDO:0031062 | polycystic kidney disease 7 | |
MONDO:0031068 | charcot-marie-tooth disease, axonal,IIa 2II | |
MONDO:0031071 | diamond-blackfan anemia 21 | |
MONDO:0031077 | spermatogenic failure 76 | |
MONDO:0031083 | spermatogenic failure 77 | |
MONDO:0031084 | amelogenesis imperfecta, IIa 1K | |
MONDO:0031166 | macular dystrophy, retinal | |
MONDO:0031240 | familial panic disorder | |
MONDO:0031323 | cardiac valvular defect | |
MONDO:0031422 | familial mucolipidosis | |
MONDO:0031520 | familial severe combined immunodeficiency | |
MONDO:0031615 | familial bent bone dysplasia syndrome | |
MONDO:0031646 | Braddock-Carey syndrome | |
MONDO:0100049 | narcolepsy, susceptibility to | An inherited susceptibility or predisposition to developing narcolepsy. |
MONDO:0100098 | dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive | A dopa-responsive dystonia characterized by marked motor delay, but no intellectual disablity, and only minimal, if any, hyperphenylalaninemia. |
MONDO:0100119 | Knobloch syndrome 2 | |
MONDO:0100122 | UDP-N-acetylglucosamine-1-phosphotransferase subunit alpha/beta deficiency | An autosomal recessive mucolipidosis disorder caused by bi-allelic variants in the GNPTAB gene. Symptoms of this condition occur across a clinical spectrum including mucolipidosis type II (ML II) and mucolipidosis type III alpha/beta (ML IIIα/β), and phenotypes intermediate between ML II and ML IIIα/β. |
MONDO:0100123 | toxic bronchiolitis | Bronchiolitis as a response to a toxic exposure. |
MONDO:0100127 | toxic bronchiolitis obliterans | Toxic bronchiolitis whereby a biospy has shown an obliteration of broncioles. |
MONDO:0100153 | tubulinopathy | A nervous system disorder characterized by complex cortical malformations including in most cases dysmorphic basal ganglia in which the cause of the disease is a variation in one or more of the tubulin genes. |
MONDO:0100154 | TUBB3-related tubulinopathy | A tubulinopathy syndrome associated with malformations of cortical development, axon guidance defects, white matter abnormalities, and/or congenital fibrosis of the extraocular muscles (CFEOM), due to de novo or dominantly inherited variants with high penetrance. Individuals may present with variable combinations of malformations of cortical development, dysplasia of the basal ganglia, brainstem, and/or cerebellum, CFEOM, additional cranial nerve involvement, Kallmann syndrome, cyclic vomiting, peripheral neuropathy, and/or contractures. Developmental delays, intellectual disability, ocular motor apraxia, and mirror movements are also frequent features. |
MONDO:0100155 | retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome | An autosomal recessive, multisystem condition caused by pathogenic variants of the PNPLA6 gene, encoding the patatin like phospholipase domain containing 6 protein. RAPH syndrome is characterized by hypogonadism, cerebellar ataxia, retinal dystrophy, peripheral neuropathy, growth hormone deficiency, and cognitive impairment. Additional clinical features may include lower limb spasticity, trichomegaly, alopecia, and facial dismorphism. The term lumps Boucher-Neuhauser, Gordon Holmes, Laurence-Moon, and Oliver-McFarlene syndromes. |
MONDO:0100159 | pulmonary hypertension, neonatal | Abnormally high blood pressure in a newborn child. |
MONDO:0100166 | PPP2R1A-related intellectual disability | Any intellectual disability in which the cause of the disease is a mutation in the PPP2R1A gene. |
MONDO:0100168 | desmoid tumor caused by somatic mutation | |
MONDO:0100169 | polyneuropathy, inflammatory demyelinating, chronic | |
MONDO:0100170 | restless legs syndrome, susceptibility to | An inherited susceptibility or predisposition to developing restless legs syndrome. |
MONDO:0100171 | psoriasis, susceptibility to | An inherited susceptibility or predisposition to developing psoriasis. |
MONDO:0100173 | leukemia, acute myeloid, susceptibility to | An inherited susceptibility or predisposition to developing leukemia, acute myeloid. |
MONDO:0100174 | age related macular degeneration, susceptibility to | An inherited susceptibility or predisposition to developing age related macular degeneration. |
MONDO:0100177 | allergic rhinitis, susceptibility to | An inherited susceptibility or predisposition to developing allergic rhinitis. |
MONDO:0100178 | dermatitis, atopic, susceptibility to | An inherited susceptibility or predisposition to developing atopic dermatitis. |
MONDO:0100179 | Hirschsprung disease, susceptibility to | An inherited susceptibility or predisposition to developing Hirschsprung disease. |
MONDO:0100180 | diabetes mellitus, ketosis-prone | An inherited susceptibility or predisposition to developing diabetes mellitus, ketosis. |
MONDO:0100181 | dermatitis, atopic, 1 | An inherited susceptibility or predisposition to developing atopic dermatitis. A genomewide linkage study revealed highly significant evidence for linkage on 3q21 (ATOD1) at marker D3S3606. |
MONDO:0100182 | schizophrenia, susceptibility to | An inherited susceptibility or predisposition to developing schizophrenia. |
MONDO:0100183 | radioulnar synostosis, nonsyndromic, susceptibility to | A susceptibility or predisposition to radioulnar synostosis in which the cause of the disease is a mutation in the SMAD6 gene. |
MONDO:0100187 | opioid-induced constipation | A constipation disorder caused by use of opiods. OIC may present immediately when a patient takes the opioid, or it may present gradually during opioid therapy. |
MONDO:0100501 | body-stalk anomaly | A very rare anomaly (1 in 14,000 to 42,000 pregnancies; 1 in 7500 fetuses from 10 to 14 weeks of gestation) characterized by a complex anomaly of the anterior abdominal wall, severe kyphoscoliosis, rudimentary umbilical cord, and anatomical defects of the pelvis and lower limbs. |
MONDO:0700115 | proliferative vitreoretinopathy | Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes. |
MONDO:0700116 | microcephaly with lissencephaly and/or hydranencephaly | A brain disorder caused by biallelic variants in NDE1 that is characterized by extreme microcephaly (typically head circumference of more than 10 standard deviations (SD) below the mean), profound motor and intellectual disability, spasticity, and incomplete cerebral formation. Radiologic studies demonstrate overt microcephaly with cortical dysgenesis ranging from simplification to pachygyria/lissencephaly to hydranencephaly. Agenesis of the corpus callosum as well as hypoplasia of the brainstem and cerebellum are typically present. |
MONDO:0700117 | SLC6A3-related dopamine transporter deficiency syndrome | A complex movement disorder characterized by tremor, rigidity, bradykinesia, chorea, reduced facial expression, and Parkinsonism-dystonia. This disease is caused by loss of function variants in the SLC6A3 gene, which impair the dopamine transporter protein. The onset of this disease ranges from infancy to adulthood. |
MONDO:0700200 | atypical dopamine transporter deficiency syndrome | A subset of SLC6A3-related DTDS cases which have later onset which ranges from late childhood to adulthood. This disorder ... |
v2022-11-01
Overview:
- Number of new terms: 71
- Number of changed labels: 0
- Number of changed definitions: 3
- Number obsoleted terms: 3
- Number of new obsoletion candidates: 1
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100048 | graft-versus-host disease, susceptibility to | An inherited susceptibility or predisposition to developing graft vs. host disease. |
MONDO:0700112 | heterotaxy, visceral, 5, autosomal | Any visceral hetetotaxy in which the cause of the disease is a mutation in the NODAL gene. |
MONDO:0700131 | sarcoma, non-human animal | Sarcoma that occurs in non-human animals. |
MONDO:0700132 | melanoma, non-human animal | Melanoma that occurs in non-human animals. |
MONDO:0700133 | adenoma, non-human | Adenoma that occurs in non-human animals. |
MONDO:0700134 | bovine neoplasm | A neoplasm that occurs in cattle. |
MONDO:0700135 | bovine leukemia | A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood which occurs in cattle |
MONDO:0700136 | bovine protoporphyria | A congenital metabolic disorder characterized by a deficiency in the enzyme ferrochelatase, which occurs in cattle. |
MONDO:0700137 | bovine lymphosarcoma | Lymphosarcoma that occurs in a cow. |
MONDO:0700138 | bovine rectal myxoma | A myxoma that occurs in the rectum of a cow. |
MONDO:0700139 | canine neoplasm | A neoplasm that occurs in dogs. |
MONDO:0700140 | canine osteosarcoma | An osteosarcoma of mesenchymal origin in a dog. It is the most common bone cancer in dogs, most often developing in the limbs of large or giant breed dogs. The morphologic and biologic behavior of canine osteosarcomas is similar to that of human osteosarcomas. |
MONDO:0700141 | canine melanoma | Melanoma occurring in a dog. It is the most common malignant tumor found in the mouths of dogs and also occurs frequently on the digits. All canine melanomas are locally invasive and malignant canine melanomas show a high rate of metastasis. Melanoma in dogs has been established as a relevant model for human melanoma. |
MONDO:0700142 | canine hemangiosarcoma | Hemangiosarcoma occurring in a dog. It is an incurable tumor of vascular endothelial cells and occurs more commonly in dogs beyond middle age, and is especially common in certain breeds. Most hemangiosarcomas do not have a known cause. |
MONDO:0700143 | canine mammary carcinoma | Mammary carcinoma occurring in a dog. |
MONDO:0700144 | canine leukemia | An acute or chronic malignant (clonal) hematologic disorder, arising from hematopoietic stem cells in dogs. It is characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. |
MONDO:0700145 | canine lymphoma | A malignant lymphoproliferative disorder that affects dogs. It is characterized by the clonal proliferation of B- or T-lymphocytes in the lymph nodes, bone marrow, and/or extranodal sites. |
MONDO:0700146 | canine prostate carcinoma | A malignant epithelial neoplasm arising from the prostate gland of a dog. |
MONDO:0700147 | canine histiocytic sarcoma | A malignant neoplasm that affects dogs, characterized by the presence of malignant cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes. |
MONDO:0700148 | canine transitional cell carcinoma | A malignant neoplasm that affects dogs, arising from transitional epithelium. |
MONDO:0700149 | canine sarcoma | A malignant mesenchymal neoplasm that affects dogs. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. |
MONDO:0700150 | canine mastocytoma | A tumor composed of mast cells that occurs in dogs. |
MONDO:0700151 | canine glioma | A brain or spinal cord tumor arising from glial cells that occurs in dogs. |
MONDO:0700152 | canine hepatocellular carcinoma | A malignant tumor arising from hepatocytes that occurs in dogs. |
MONDO:0700153 | canine lung adenocarcinoma | A carcinoma that arises from the lung in dogs and is characterized by the presence of malignant glandular epithelial cells. |
MONDO:0700154 | canine rhabdomyosarcoma | A malignant mesenchymal neoplasm arising from skeletal muscle that occurs in dogs. |
MONDO:0700155 | canine thyroid adenocarcinoma | Adeonocarcinoma of the thyroid gland occurring in a dog. |
MONDO:0700156 | canine soft tissue sarcoma | Soft tissue sarcoma occurring in a dog. |
MONDO:0700157 | canine oral squamous cell carcinoma | Oral squamous cell carcinoma that occurs in a dog. |
MONDO:0700158 | canine pancreatic carcinoma | Pancreatic carcinoma that occurs in a dog. |
MONDO:0700159 | canine acanthomatous epulis | A tumor arising from odontogenic epithelium and occurs in a dog. |
MONDO:0700160 | canine mammary adenoma | An adenoma arising from the mammary gland of a dog. |
MONDO:0700161 | canine gastrointestinal stromal tumor | A gastrointestinal stromal tumor occurring in a dog. |
MONDO:0700162 | canine granular cell tumor | A granular cell tumor occurring in a dog. |
MONDO:0700163 | canine Langerhans cell histiocytosis | Langerhans cell histiocytosis occurring in a dog. |
MONDO:0700164 | canine nephroblastoma | A nephroblastoma occurring in a dog. |
MONDO:0700165 | canine thyroid gland medullary carcinoma | Thyroid gland medullary carcinoma occurring in a dog. |
MONDO:0700166 | canine transmissible venereal tumor | A sexually transmitted tumor arising from histiocytes and occurring in dogs. |
MONDO:0700167 | canine sebaceous gland epithelioma | Sebaceous epithelioma occurring in a dog. |
MONDO:0700168 | canine oral melanoma | A melanoma that affects the lip and/or oral cavity of a dog. |
MONDO:0700169 | canine cutaneous t-cell lymphoma | Cutaneous T-cell lymphoma occurring in a dog. |
MONDO:0700170 | equine neoplasm | Neoplasm that occurs in a horse. |
MONDO:0700171 | horse melanoma | Melanoma that occurs in a horse. |
MONDO:0700172 | horse lymphoma | Lymphoma that occurs in a horse. |
MONDO:0700173 | horse sarcoid | A fibroblastic tumor that occurs in the skin of a horse. |
MONDO:0700174 | horse transitional cell carcinoma | Transitional cell carcinoma that occurs in a horse. |
MONDO:0700175 | feline neoplasm | Neoplasm that occurs in a cat. |
MONDO:0700176 | feline lymphoma | A lymphoma that occurs in cats. It is associated with exposure to feline leukemia virus and feline immunodeficiency virus. |
MONDO:0700177 | feline mammary carcinoma | Mammary carcinoma occurring in a cat. |
MONDO:0700178 | feline oral squamous cell carcinoma | Oral squamous cell carcinoma that occurs in a cat. |
MONDO:0700179 | feline osteosarcoma | Osteosarcoma that occurs in a cat. |
MONDO:0700180 | feline bronchioloalveolar lung carcinoma | Bronchioloalveolar lung carcinoma that occurs in a cat. |
MONDO:0700181 | feline fibrosarcoma | Fibrosarcoma that occurs in a cat. |
MONDO:0700182 | feline erythroleukemia | Erythroleukemia that occurs in a cat. |
MONDO:0700183 | feline reticulum cell sarcoma | Reticulum cell sarcoma that occurs in a cat. |
MONDO:0700184 | feline large granular lymphocyte lymphoma | A T-cell leukemia in which there is a persistent increase in the number of large granular lymphocytes in the peripheral blood and occurring in a cat. |
MONDO:0700185 | feline melanoma | A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that occurs in a cat. |
MONDO:0700186 | feline histiocytic sarcoma | Histiocytic sarcoma occurring in a cat. |
MONDO:0700187 | feline progressive histiocytosis | A condition occurring in cats characterized by solitary or multiple cutaneous nodules and papules, which may metastasize late in the course of the disease. Lesions consist of poorly circumscribed histiocytic infiltrates of the superficial and deep dermis, with variable extension into the subcutis. |
MONDO:0700188 | feline synovial cell sarcoma | Synovial cell sarcoma occurring in a cat. |
MONDO:0700189 | chicken neoplasm | A neoplasm that occurs in a chicken. |
MONDO:0700190 | chicken bursal lymphoma | A malignant lymphoma that arises in the bursa of Fabricius in a chicken. |
MONDO:0700191 | chicken fibrosarcoma | Fibrosarcoma that occurs in a chicken. |
MONDO:0700192 | chicken hepatoma | Hepatoma that occurs in a chicken. |
MONDO:0700193 | chicken monocytic leukemia | Monocytic leukemia that occurs in a chicken. |
MONDO:0700194 | chicken lymphoma | Lymphoma that occurs in a chicken. |
MONDO:0700195 | rous sarcoma | A fibrosarcoma, originally observed in a Plymouth Rock hen, now thought to be an expression of infection by certain viruses of the avian leukosis-sarcoma complex in the family |
MONDO:0700196 | fish melanoma | Melanoma that occurs in a fish. |
MONDO:0700197 | porcine leukemia | Leukemia that occurs in a pig. |
MONDO:0700198 | porcine lymphoma | Lymphoma that occurs in a pig. |
MONDO:0700199 | sheep lung adenocarcinoma | Adenocarcinoma arising from the lung of a sheep. |
Changed terms
No changed labels.
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0009821 | lethal osteosclerotic bone dysplasia | Lethal osteosclerotic bone dysplasia is defined by generalized osteosclerosis with periosteal bone formation, characteristic facial dysmorphism, brain abnormalities including intracerebral calcifications, and neonatal lethal course. | Generalized osteosclerosis with periosteal bone formation, characteristic facial dysmorphism, brain abnormalities including intracerebral calcifications, and neonatal lethal course. |
MONDO:0013730 | graft versus host disease | Acute graft-versus-host disease ... |
v2022-10-11
Overview:
- Number of new terms: 38
- Number of changed labels: 4
- Number of changed definitions: 69
- Number obsoleted terms: 6
- Number of new obsoletion candidates: 3
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100043 | epidermodysplasia verruciformis, susceptibility to | |
MONDO:0100045 | epidermodysplasia verruciformis, susceptibility to, 1 | |
MONDO:0100046 | exfoliation syndrome, susceptibility to | An inherited susceptibility or predisposition to developing exfoliation syndrome. |
MONDO:0100047 | basal cell carcinoma, susceptibility to | An inherited susceptibility or predisposition to developing basal cell carcinoma. |
MONDO:0800109 | persistent tachypnoe of infancy | A interstial lung disease characterized by the presence of persistent or intermittent tachypnea (usually noticed in neonatal period or after an acute infection for the first time in first months of life), crackles in 86 %, retractions in 82%, failure to thrive in 66%, chest wall abnormalities in 22% and hypoxemia or desaturation in 88%. |
MONDO:0800110 | persistent tachypnoe of infancy, aberrant | Persistent tachypnoe of infancy that presents with additional minor abnormalities upon scanning, including ground-glass opacities in other locations, focal consolidations, parenchymal cysts or bronchial wall thickening (N=80; 37%). |
MONDO:0800111 | persistent tachypnoe of infancy, usual | Persistent tachypnoe of infancy that presents with with no other airway or parenchymal abnormalities upon scanning (N=80; 63%). |
MONDO:0800112 | non-atopic asthma | A type of asthma that isn't related to an allergy trigger like pollen or dust, and is less common than atopic asthma. |
MONDO:0800113 | necrotizing vasculitis | A type of vasculitis that is comprised of vasculitides that present with necrosis. |
MONDO:0800114 | follicular bronchiolits | A polyclonal hyperplasia of bronchiolar associated lymphoid tissue characterized by the development of lymphoid follicles with germinal centers in walls of the small airways. |
MONDO:0800117 | cutaneous botryomycosis | A botromycosis that involves the skin and subcutaneous tissue (it is a more common type). |
MONDO:0800118 | visceral botryomycosis | A botryomycosis that involves internal organs such as lungs, liver, or brain. It is a rare disease and has been described mainly in patients with underlying diseases such as diabetes mellitus, cystic fibrosis, or HIV infection. It is most commonly affecting the lungs, although involvement of other organs including liver, spleen, kidney, and brain has also been described. |
MONDO:0800119 | postinfectious bronchiolitis obliterans | An irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respiratory tract infection during childhood, especially early childhood. Although diagnosis of PIBO should be confirmed by histopathology, it is generally based on history and clinical findings. Irreversible airway obstruction is demonstrated by decreased forced expiratory volume in 1 second with an absent bronchodilator response, and by mosaic perfusion, air trapping, and/or bronchiectasis on computed tomography images. However, lung function tests using spirometry are not feasible in young children, and most cases of PIBO develop during early childhood. |
MONDO:0800120 | Mac-Leod-Swyer-James-Syndrome | A rare lung condidtion characterized by often predominantly unilateral lung hyperlucency and air trapping. The condition is a post-infectious form of bronchiolitis obliterans and typically follows a viral respiratory infection in infancy and childhood. Adenovirus infection is considered the most usual epidemiology. In SJS, the involved lung or portion of the lung does not grow normally and is slightly smaller than the opposite lung: in particular, peripheral branches of the pulmonary vessels do not develop, and vasculature is arreseted at the stage at which the infection occurred. Patients respond well to management with bronchodilators, even though this is not primarily a bronchial abnormality. |
MONDO:0800121 | cellular interstitial pneumonitis | An interstitial lung disease specific to infancy that is characterized by tachypnea at birth and persistent disease, diffuse interstitial thickening due to pale oval and spindle-shaped histiocytes without scarring. |
MONDO:0800123 | bronchiolocentric pattern of interstitial pneumonia | An interstitial lung disease characterized histologically by fibrosis and/or inflammation confined to the alveolar interstitium around bronchovascular bundles, overlapping with peribronchial metaplasia, fibrosis in some series and the lack of interstitial granulomas. |
MONDO:0800124 | Lane Hamilton syndrome | A rare concurrent association of idiopathic pulmonary hemosiderosis and celiac disease, and is typically seen in children under the age of 15. |
MONDO:0800125 | disseminated visceral giant cell angiitis | A necrotizing vasculitis characterized by widespread small-vessel giant cell angitis and extravascular granulomas. |
MONDO:0800126 | dystrophic pulmonary ossification | A rare lung disorder characterized by ectopic bone formation within lung parenchyma. DPO can be idiopathic or associated with a variety of cardiovascular, respiratory diseases or other disorders. There are mainly two forms of DPO: nodular and dendriform. |
MONDO:0800127 | pulmonary amyloidosis | A rare hereditary amyloidosis that incorporates deposition of amyloid microfibril material in the lung parenchyma. |
MONDO:0800128 | combined immunodeficiency due to POLE2 deficiency | Any combined immunodeficiency due to a deficiency in the POLE2 gene. |
MONDO:0800129 | autoinflammatory disease, X-linked | An autoinflammatory syndrome characterized by the onset of systemic autoinflammation in the first months of life. Features include lymphadenopathy, hepatosplenomegaly, fever, panniculitis, and nodular skin rash. Additional manifestations may include inflammation of the optic nerve, intracranial hemorrhage, and lipodystrophy. |
MONDO:0800130 | autoinflammatory syndrome with immunodeficiency | An autoinflammatory syndrome characterized by onset of various autoimmune features usually in the first decades of life, although later onset has been reported. Typical features include autoimmune cytopenia, hemolytic anemia, thrombocytopenia, and lymphadenopathy. More variable features may include autoimmune thyroiditis, psoriasis or eczema, nephritis, hepatitis, and symptoms of systemic lupus erythematosus (SL). Some patients may have recurrent infections or exacerbation of the disease with acute infection. Laboratory studies show variable findings, often decreased numbers of naive B cells, lymphopenia with skewed subsets, hypogammaglobulinemia, presence of autoantibodies, and a hyperinflammatory state. The disorder shows autosomal dominant inheritance with incomplete penetrance. |
MONDO:0800131 | hyper-IgE recurrent infection syndrome 4A, autosomal dominant | An immunologic disorder characterized by recurrent mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 and IL11 signaling. |
MONDO:0800132 | autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency | An autosomal recessive disorder characterized by severe anemia and thrombocytopenia apparent from early infancy, hepatosplenomegaly, and recurrent fevers associated with a hyperinflammatory state. Additional systemic features may include chronic diarrhea, proteinuria with renal disease, liver fibrosis with elevated liver enzymes, deforming arthropathy, and vasculitic skin lesions. Some patients may have motor delay or learning difficulties associated with subcortical white matter lesions on brain imaging. Laboratory studies show increased levels of proinflammatory cytokines and increased expression of interferon-stimulated genes (ISGs), consistent with a type I interferonopathy. |
MONDO:0800133 | pulmonary hypoplasia | A respiratory malformation characterized by the presence of both bronchi (albeit rudimentary) and alveoli in an under-developed lobe. Both the size and the weight of the lung are reduced. The true prevalence is not well known (1.4% of all births according to Knox et al. 13), but in cases of premature rupture of membranes at 15-28 weeks gestation, the reported prevalence of pulmonary hypoplasia ranges from 9 to 28%. Factors that contribute to pulmonary hypoplasia include adequate volume of the thoracic cavity, pulmonary fluid dynamics, and abnormal fetal breathing movements. |
MONDO:0800174 | encephalitis, acute, infection-induced, susceptibility to | An inherited susceptibility or predisposition to developing encephalitis, acute, infection-induced. |
MONDO:0800175 | cardiogenic shock | A rare, cardiac condition characterized by severely decreased cardiac output, hypoperfusion and end-organ dysfunction, in the presence of adequate intravascular volume. The clinical presentation is variable and may range from subtle hemodynamic alterations to overt cardiovascular collapse. Commonly reported features include dyspnea,... |
v2022-10-03
Overview:
- Number of new terms: 34
- Number of changed labels: 47
- Number of changed definitions: 7
- Number obsoleted terms: 10
- Number of new obsoletion candidates: 4
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100478 | brain malformations with or without urinary tract defects | A brain disorder caused by pathogenic variants in NFIA that is characterized by developmental delay, corpus callosum agenesis/hypoplasia and craniofacial dysmorphism, such as macrocephaly (caused by hydrocephalus or ventriculomegaly), low-set ears, anteverted nostrils and micrognathia. Urinary tract defects (e.g. vesicoureteral reflux, urinary incontinence) are also frequently associated. Other reported variable manifestations include hypotonia, tethered spinal cord, Chiari type I malformation and seizures. |
MONDO:0100500 | Mendelian neurodevelopmental disorder | A neurodevelopmental disorder that is caused by genetic modifications where those modifications are inherited from a parent's genome. |
MONDO:0700096 | human disease or disorder | |
MONDO:0700098 | neoplasm, non-human animal | |
MONDO:0700099 | adenocarcinoma, non-human animal | |
MONDO:0700100 | leukemia, non-human animal | |
MONDO:0700101 | carcinoma, non-human animal | |
MONDO:0700102 | lymphoma, non-human animal | |
MONDO:0700103 | nutritional deficiency disease, non-human animal | |
MONDO:0700104 | respiratory system disorder, non-human animal | |
MONDO:0700105 | difference of sexual differentiation, non-human animal | |
MONDO:0700106 | immune system disorder, non-human animal | |
MONDO:0700108 | prion disease, non-human animal | |
MONDO:0700109 | skin disease caused by bacterial infection, non-human animal | |
MONDO:0700110 | pneumonia, non-human animal | |
MONDO:0700111 | bacterial pneumonia, non-human animal | |
MONDO:0800103 | COACH syndrome 1 | Any COACH syndrome in which the cause of the disease is a variation in the TMEM67 gene. |
MONDO:0800134 | primary immunodeficiency due to calcium channel deficiency | An immunodeficiency disease caused by a variation in the CRACR2A gene. |
MONDO:0800135 | congenital emphysematous lung disease due to Filamin A loss-of-function variant | Any interstitial lung disease specific to childhood caused by a loss-of-function variation in the FLNA gene. Female children are reported more often. Rare male patients with loss-of-function FLNA mutation-associated lung disease with residual protein function can survive into infancy with a severe form of the phenotype. |
MONDO:0800136 | non-severe combined immunodeficiency due to COPG1 deficiency | Any non-severe combined immunodeficiency caused by a deficiency in the COPG1 gene. |
MONDO:0800137 | early-onset pulmonary and cutaneous vasculitis | A monogenic autoinflammatory disorder caused by a de novo activating mutation, p.Tyr515∗, in hematopoietic cell kinase (HCK). The disease is characterized by cutaneous vasculitis and chronic pulmonary inflammation that progresses to fibrosis. |
MONDO:0800138 | multisystem autoimmune disease due to IKAROS gain of function | An autoimmune disease caused by a loss-of-function variation in the IKZF1/IKAROSgene. Leukocytes of patients exhibited specific defects including impaired IL-2 production by T cells, T helper (TH) skewing toward TH2, low numbers of regulatory T cells (Treg), eosinophilia, and abnormal PC proliferation. |
MONDO:0800139 | HELIOS deficiency | A non-severe combined immunodeficiency caused by a loss-of-function variation in the IKZF2 gene that is characterized by recurrent upper respiratory infections, thrush and mucosal ulcers, and chronic lymphadenopathy. |
MONDO:0800140 | ITPKB deficiency | Any non-severe combined immunodeficiency in which the cause of the disease is variation in the ITPKB gene. |
MONDO:0800141 | MAN2B2 deficiency | Any non-severe combined immunodeficiency in which the cause of the disease is variation in the MAN2B2 gene. |
MONDO:0800142 | chronic mucocutaneous candidiasis and connective tissue disease due to JNK1 haploinsufficiency | An immunodeficiency disease caused by a variation in MAPK8, the gene encoding c-Jun N-terminal kinase 1 (JNK1), that is characterized by chronic mucocutaneous candidiasis and a connective tissue disorder that clinically overlaps with Ehlers-Danlos syndrome (EDS). |
MONDO:0800143 | cytomegalovirus pneumonia due to NOS2 deficiency | Cytomegalovirus pneumonia due to variant in the NOS2 gene. |
MONDO:0800144 | autoimmune pulmonary disease due to PD-1 deficiency | An autoimmune disease that is characterized by a lack of PD-1 on patient peripheral blood mononuclear cells (PBMCs) and reduced IFN production in response to mycobacterial stimuli. |
MONDO:0800145 | non-severe combined immunodeficiency due to polymerase delta deficiency | Any non-severe combined immunodeficiency in which the cause of the disease is variation in the POLD1/POLD2 gene. |
MONDO:0800146 | agammaglobulinemia, autosomal recessive, due to BOB1 deficiency | Any agammaglobulinemia in which the cause of the disease is autosomal recessive deficiency in the BOB1 gene. |
MONDO:0800147 | hemophagocytic lymphohistiocytosis due to RhoG deficiency | Any genetic hemophagocytic lymphohistiocytosis in which the cause of the disease is an autosomal recessive variation in the RHOG gene. |
MONDO:0800148 | autoinflammatory syndrome due to TBK1 deficiency | Any autoinflammatory syndrome in which the cause of the disease is an autosomal recessive variation in the TBK1 gene. |
MONDO:0800149 | immunodeficiency, common variable, due to APRIL deficiency | Any commonn variable immunodeficiency in which the cause of the disease is an autosomal recessive variation in the TNFS13 gene. |
MONDO:0810000 | choroidal neovascularization | An eye disorder described by the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space. Choroidal neovascularization (CNV) is a major cause of visual loss. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0001571 | gynecomastia disorder | gynecomastia | gynecomastia disorder |
MONDO:0002145 | disorder of sexual differentiation | difference of sexual differentiation | disorder of sexual differentiation |
MONDO:0005272 | myelodysplastic syndrome with single lineage dysplasia | refractory anemia | myelodysplastic syndrome with single lineage dysplasia |
MONDO:0019453 | myelodysplastic syndrome with multilineage dysplasia | refractory cytopenia with multilineage dysplasia | myelodysplastic syndrome with multilineage dysplasia |
MONDO:0007925 | myelodysplastic syndrome associated with isolated del(5q) | chromosome 5q deletion syndrome | myelodysplastic syndrome associated with isolated del(5q) |
MONDO:0008907 | PMM2-congenital disorder of glycosylation | PMM2-CDG | PMM2-congenital disorder of glycosylation |
MONDO:0008908 | MGAT2-congenital disorder of glycosylation | MGAT2-CDG | MGAT2-congenital disorder of glycosylation |
MONDO:0012117 | ALG9-congenital disorder of glycosylation | ALG9-CDG | ALG9-congenital disorder of glycosylation |
MONDO:0010478 | SLC35A2-congenital disorder of glycosylation | SLC35A2-CDG | SLC35A2-congenital disorder of glycosylation |
MONDO:0010490 | SSR4-congenital disorder of glycosylation | SSR4-CDG | SSR4-congenital disorder of glycosylation |
MONDO:0010998 | ALG3-congenital disorder of glycosylation | ALG3-CDG | ALG3-congenital disorder of glycosylation |
MONDO:0011257 | MPI-congenital disorder of glycosylation | MPI-CDG | MPI-congenital disorder of glycosylation |
MONDO:0011291 | ALG6-congenital disorder of glycosylation 1C | congenital disorder of glycosylation type 1C | ALG6-congenital disorder of glycosylation 1C |
MONDO:0011342 | SLC35A1-congenital disorder of glycosylation | SLC35A1-CDG | SLC35A1-congenital disorder of glycosylation |
MONDO:0011629 | MOGS-congenital disorder of glycosylation | MOGS-CDG | MOGS-congenital disorder of glycosylation |
MONDO:0011772 | B4GALT1-congenital disorder of glycosylation | B4GALT1-CDG | B4GALT1-congenital disorder of glycosylation |
MONDO:0011783 | ALG12-congenital disorder of glycosylation | ALG12-CDG | ALG12-congenital disorder of glycosylation |
MONDO:0011933 | ALG2-congenital disorder of glycosylation | ALG2-CDG | ALG2-congenital disorder of glycosylation |
MONDO:0011964 | DPAGT1-congenital disorder of glycosylation | DPAGT1-CDG | DPAGT1-congenital disorder of glycosylation |
MONDO:0011969 | ALG8-congenital disorder of glycosylation | ALG8-CDG | ALG8-congenital disorder of glycosylation |
MONDO:0012041 | familial adenomatous polyposis 2 | MUTYH-related attenuated familial adenomatous polyposis | familial adenomatous polyposis 2 |
MONDO:0012052 | ALG1-congenital disorder of glycosylation | ALG1-CDG | ALG1-congenital disorder of glycosylation |
MONDO:0012118 | COG7-congenital disorder of glycosylation | COG7-CDG | COG7-congenital disorder of glycosylation |
MONDO:0012128 | transposition of the great arteries, dextro-looped | dextro-looped transposition of the great arteries 1 | transposition of the great arteries, dextro-looped |
MONDO:0012211 | MPDU1-congenital disorder of glycosylation | MPDU1-CDG | MPDU1-congenital disorder of glycosylation |
MONDO:0012556 | DK1-congenital disorder of glycosylation | DK1-CDG | DK1-congenital disorder of glycosylation |
MONDO:0012635 | COG8-congenital disorder of glycosylation | COG8-CDG | COG8-congenital disorder of glycosylation |
MONDO:0012637 | COG1-congenital disorder of glycosylation | COG1-CDG | COG1-congenital disorder of glycosylation |
MONDO:0012783 | RFT1-congenital disorder of glycosyla... |
v2022-09-06
Overview:
- Number of new terms: 19
- Number of changed labels: 15
- Number of changed definitions: 70
- Number obsoleted terms: 42
- Number of new obsoletion candidates: 5
- Number of terms who were previously candidate for obsoletion and are now not anymore: 43
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100434 | chronic mountain sickness | A pathological condition resulting from chronic exposure to hypoxia at high altitude. The syndrome is characterized by an excessive number of red blood cells associated with a high blood hemoglobin concentration ([Hb]), hypoxemia, and, in some cases, pulmonary hypertension. Clinical signs include headache, fatigue, sleep disturbances, dyspnea, digestive complaints, and high risk of thrombotic events. |
MONDO:0100440 | Asperger syndrome, susceptibility to | An inherited susceptibility or predisposition to developing Asperger sydrome. |
MONDO:0100473 | disorder of peptide and amine metabolism | An inherited metabolic disease that has its basis in the disruption of peptide and/or amine metabolic process. |
MONDO:0100477 | disorder of methylamine metabolism | An inherited metabolic disease that has its basis in the disruption of methylamine metabolic process. |
MONDO:0100509 | IFT140-related recessive ciliopathy | Any ciliopathy in which the cause of the disease is biallelic variants in the IFT140 gene. |
MONDO:0100510 | spondyloepimetaphyseal dysplasia | An osteochondrodysplasia that results in abnormalities of bone growth in the vertebral column, epiphysis, and metaphysis. |
MONDO:0100514 | familial ovarian carcinoma | Ovarian carcinoma that has developed in relatives of patients that have a history of ovarian carcinoma. |
MONDO:0100515 | mirror movements 1 and/or agenesis of the corpus callosum | A familial congenital mirror movement disorder where individuals with heterozygous variants in DCC have congenital mirror movements and/or agenesis of the corpus callosum (not with or without- some individuals do not demonstrate mirror movements and only have corpus callosum defects, even within the same family). |
MONDO:0100516 | complex neurodevelopmental disorder with motor features | A complex neurodevelopmental disorder that involves more than one phenotype associated with the central nervous system, including but not limited to intellectual disability, autism, and seizures (epilepsy). Additionally, the disorder features at least one phenotype associated with motor function, including but not limited to spasticity, hypo- or hypertonia, dyskinesia, choreo-athetosis, or ataxia. |
MONDO:0800107 | anterior deviation infundibular septum | |
MONDO:0800108 | cleft leaflet of tricuspid valve | |
MONDO:0800152 | disorder of galactose and fructose metabolism | An inherited disorder of carbohydrate metabolism that is has its basis in the disruption of galactose and/or fructose metabolic process. |
MONDO:0800153 | urea cycle disorder or inherited hyperammonemia | A disorder of amino acid metabolism that has its basis in the disruption of the urea cycle and/or there is an inherited increased concentration of ammonia in the blood. |
MONDO:0800154 | inborn disorder of the metabolism of sulfur-containing amino acids and hydrogen sulfide | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of sulfur-containing amino acids and/or hydrogen sulfide. |
MONDO:0800155 | inborn disorder of glycine and serine metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of glycine and/or serine. |
MONDO:0800156 | inborn disorder of ornithine, proline and hydroxyproline metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of ornithine, proline and/or hydroxyproline. |
MONDO:0800157 | inborn disorder of lysine, hydroxylysine, and tryptophan metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of lysine, hydroxylysine, and/or tryptophan. |
MONDO:0800158 | inborn disorder of glutamate/glutamine and aspartate/asparagine metabolism | A disorder of amino acid metabolism that has its basis in the disruption of the metabolism of glutamate/glutamine and aspartate/asparagine. |
MONDO:0800159 | disorder of polyamine metabolism | An inherited metabolic disease that has its basis in the disruption of the polyamine metabolic process. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0004736 | inborn disorder of amino acid metabolism | inherited amino acid metabolic disorder | inborn disorder of amino acid metabolism |
MONDO:0000688 | inborn organic aciduria | inherited organic acidemia | inborn organic aciduria |
MONDO:0002412 | disorder of glycogen metabolism | glycogen storage disease | disorder of glycogen metabolism |
MONDO:0019216 | inborn disorder of amino acid transport | inborn disorder of amino acid absorption and transport | inborn disorder of amino acid transport |
MONDO:0017706 | disorder of carbohydrate transmembrane transport and absorption | disorder of carbohydrate absorption and transport | disorder of carbohydrate transmembrane transport and absorption |
MONDO:0019225 | disorder of gluconeogenesis | gluconeogenesis disorder | disorder of gluconeogenesis |
MONDO:0010078 | spondyloperipheral dysplasia | spondyloperipheral dysplasia-short ulna syndrome | spondyloperipheral dysplasia |
MONDO:0010888 | adenomyosis | endometriosis of uterus | adenomyosis |
MONDO:0016200 | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase - | qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
MONDO:0014502 | Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency | Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency |
MONDO:0016182 | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase | qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase | qualitative or quantitative defects of protein O-mannose beta1, 2N-acetylglucosaminyltransferase |
MONDO:0016454 | Charcot-Marie-Tooth disease type 2B5 | severe early-onset axonal neuropathy due to NEFL deficiency | Charcot-Marie-Tooth disease type 2B5 |
MONDO:0019235 | inborn disorder of phenylalanine and tyrosine metabolism | inborn disorder of phenylalanin or tyrosine metabolism | inborn disorder of phenylalanine and tyrosine metabolism |
MONDO:0019223 | disorder of fatty acid and ketone body metabolism | inborn disorder of fatty acid oxidation and ketone body metabolism | disorder of fatty acid and ketone body metabolism |
MONDO:0017900 | autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency | autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency | autosomal recessive Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0000155 | triglyceride storage disease | An acquired metabolic disease that is has its basis in the disruption of sequestering of triglyceride. | An inherited metabolic disease that is has its basis in the disruption of sequestering of triglyceride. |
MONDO:0019226 | glucose transport disorder | An acquired metabolic disease that is has its basis in the disruption of glucose transport. | An inherited metabolic disease that is has its basis in the disruption of glucose transport. |
MONDO:0000273 | Kunjin virus infectous disease | A West Nile encephalitis that results in infection located in brain, has material basis in Kunjin virus, a subtype of West Nile Virus, which is transmitted by Culex annulirostris mosquito bite. The infection has symptom fever, has symptom rigor, has symptom headache, has symptom confusion, and has symptom lethargy. | |
MONDO:0000351 | disorder of methionine catabolism | An acquired metabolic disease that is has its basis in the disruption of methionine catabolic process. | An inherited metabolic disease that is has its basis in the disruption of methionine catabolic process. |
MONDO:0019222 | inborn disorder of methionine cycle and sulfur amino acid metabolism | An acquired metabolic disease that is has its basis in the disruption of sulfur amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of sulfur amino acid metabolic process. |
MONDO:0037938 | inborn disorder of aspartate family metabolism | An acquired metabolic disease that is has its basis in the disruption of aspartate family amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of aspartate family amino acid metabolic process. |
MONDO:0000421 | inborn serine deficiency | An acquired metabolic disease that is has its basis in the disruption of L-serine biosynthetic process. | An inherited metabolic disease that is has its basis in the disruption of L-serine biosynthetic process. |
MONDO:0019239 | inborn disorder of serine family metabolism | An acquired metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process. | An inherited metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process. |
MONDO:0005528 | inborn vitamin metabolic disorder | An acquired metaboli... |
v2022-08-01
Overview:
- Number of new terms: 19
- Number of changed labels: 6
- Number of changed definitions: 35
- Number obsoleted terms: 34
- Number of new obsoletion candidates: 34
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0030827 | macrothrombocytopenia, isolated, 2, autosomal dominant | |
MONDO:0030839 | thyroid hormone metabolism, abnormal, 2 | |
MONDO:0031432 | thyroid hormone metabolism, abnormal | |
MONDO:0031447 | macrothrombocytopenia, isolated | |
MONDO:0100498 | UROD-related inherited porphyria | Any inherited porphyria in which the cause of the disease is monoallelic or biallelic variants in the UROD gene. |
MONDO:0100502 | NTHL1-deficiency tumor predisposition syndrome | Biallelic constitutional/germline loss-of-function NTHL1 variants confer predisposition to tumor formation demonstrating ‘COSMIC Signature 30’ mutation profile. Tumors have been reported at multiple primary sites; in particular adenomatous polyposis of colon (~10-50 polyps), colorectal cancer, and breast cancer. |
MONDO:0100503 | DPH5-related diphthamide-deficiency syndrome | A neurodevelopmental disorder in which the cause of the disease is a mutation in the DPH5 gene, which is characterized by craniofacial dysmorphology, profound neurodevelopmental delay, multisystem abnormalities, and miscarriages. |
MONDO:0100504 | fungal infection of the toenail | A fungal infectious disease that involves the toenail. |
MONDO:0100505 | food dermatitis | Dermatitis caused by an allergic reaction to ingested food. |
MONDO:0100506 | Cockayne spectrum with or without cerebrooculofacioskeletal syndrome | An autosomal recessive, multisystem condition caused by pathogenic variants of the ERCC6 gene, encoding the DNA excision repair protein, ERCC-6. Cockayne spectrum with or without cerebrooculofacioskeletal syndrome is characterized by growth failure at birth, with little or no postnatal neurologic development in addition to congenital cataracts or other structural anomalies of the eye, early postnatal contractures of the spine (kyphosis, scoliosis) and joints, and death usually occurring by age five years. This term lumps Cockayne syndrome type 2/B (CSB), cerebrooculofacioskeletal syndrome 1 (COFS syndrome), and De Sanctis-Cacchione syndrome into a spectrum of disease. |
MONDO:0700082 | Robertsonian translocation Down syndrome | Chromosomal disorder in which (part or full) chromosome 21 is attached to another chromosome, resulting in the presence of a third copy of part of full chromosome 21 genetic material. A Robertsonian translocation is a structural chromosomal anomaly in which two acrocentric chromosomes break, resulting in the fusion of the nonhomologous chromosomes’ long arms to form a single, large chromosome. |
MONDO:0700083 | reciprocal translocation down syndrome | Chromosomal disorder in which (part or full) chromosome 21 has been exchange with another chromosome, resulting in the presence of a third copy of (part or full) chromosome 21 genetic material. A reciprocal translocation is a chromosome abnormality caused by exchange of parts between non-homologous chromosomes. |
MONDO:0700093 | balanced Robertsonian translocation Down syndrome | Robertsonian translocation Down syndrome in which translocation displacement of the end regions of chromosomes occured without loss of chromosomal material between the two nonhomologous chromosomes. |
MONDO:0700094 | unbalanced Robertsonian translocation Down syndrome | Robertsonian translocation Down syndrome in which translocation displacement of the end regions of chromosomes occured with loss of chromosomal material between the two nonhomologous chromosomes. |
MONDO:0800046 | thyroid hormone metabolism, abnormal 1 | A rare, genetic congenital hypothyroidism disorder characterized by mild global developmental delay in childhood, short stature, delayed bone age, and abnormal thyroid and selenium levels in serum (high total and free T4 concentrations, low T3, high reverse T3, normal to high TSH, decreased selenium). Intellectual disability, primary infertility, hypotonia, muscle weakness, and impaired hearing have also been reported. |
MONDO:0800047 | macrothrombocytopenia, isolated, 1, autosomal dominant | Any autosomal dominant macrothrombocytopenia in which the cause of the disease is a mutation in the TUBB1 gene. |
MONDO:0800104 | immunodeficiency 105 | Any immunodeficiency disease which the cause of the disease is a mutation in the PTPRC gene. |
MONDO:0800105 | catatonia | A psychiatric disorder featuring stupor, posturing, and echophenomena. |
MONDO:0800106 | disruptive behavior disorder | A mental disorder that includes conduct disorder (CD), oppositional defiant disorder (ODD), and attention Deficit Hyperactivity Disorder (ADHD). Features may include frequent aggression, deceitfulness, and defiance, and often persist through the lifespan. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0007962 | megalodactyly | Megalodactyly | megalodactyly |
MONDO:0008075 | schwannomatosis | neurofibromatosis type 3 | schwannomatosis |
MONDO:0010663 | intellectual disability-hypotonic facies syndrome, X-linked, 1 | X-linked intellectual disability-hypotonic face syndrome | intellectual disability-hypotonic facies syndrome, X-linked, 1 |
MONDO:0012163 | immunodeficiency 104 | severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive | immunodeficiency 104 |
MONDO:0013784 | neonatal-onset encephalopathy with rigidity and seizures | lethal neonatal spasticity-epileptic encephalopathy syndrome | neonatal-onset encephalopathy with rigidity and seizures |
MONDO:0700130 | partial segmental duplication | partial trisomy 21 | partial segmental duplication |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0004598 | acute cor pulmonale | Acute form of cor pulmonale. | A form of acute right heart failure produced by a sudden increase in resistance to blood flow in the pulmonary circulation. |
MONDO:0017666 | diffuse palmoplantar keratoderma | Palmoplantar keratoderma that diffusely involves most of the palm and sole and is caused by a genetic abnormality. | |
MONDO:0007113 | Angelman syndrome | Angelman syndrome (AS) is a neurogenetic disorder characterized by severe intellectual deficit and distinct facial dysmorphic features. | A neurogenetic disorder characterized by severe intellectual deficit and distinct facial dysmorphic features. |
MONDO:0007168 | atelosteogenesis type III | Atelosteogenesis III (AOIII) is a skeletal dysplasia characterized by short limbs dysmorphic facies and diagnostic radiographic findings. | A skeletal dysplasia characterized by short limbs dysmorphic facies and diagnostic radiographic findings. |
MONDO:0016524 | congenital vascular bone syndrome | An alteration in limb growth caused by congenital vascular malformations in childhood | An alteration in limb growth caused by congenital vascular malformations in childhood. |
MONDO:0019270 | erythrokeratoderma | An umbrella term for a group of rare genetic skin disorders characterized by well-demarcated plaques of reddened, dry and thickened skin. Typically, these lesions are distributed symmetrically on the body and tend to slowly expand and progress over time. | |
MONDO:0008608 | Down syndrome | Down syndrome is a chromosomal abnormality caused by the presence of a third (partial or total) copy of chromosome 21 and that is characterized by variable intellectual disability, muscular hypotonia, and joint laxity, often associated with a characteristic facial dysmorphism and various anomalies such as cardiac, gastrointestinal, or endocrine defects. | Down syndrome is a chromosomal abnormality caused by the presence of a third (partial or total) copy of the chromosome 21 genetic material and that is characterized by variable intellectual disability, muscular hypotonia, and joint laxity, often associated with a characteristic facial dysmorphism and various anomalies such as cardiac, gastrointestinal, or endocrine defects. |
MONDO:0008075 | schwannomatosis | Neurofibromatosis (NF) type 3 (NF3), also known as schwannomatosis, is the least frequent form of the rare genetic disorder neurofibromatosis. It is clinically and genetically distinct from NF1 and NF2 and is characterized by the development of multiple schwannomas (nerve sheath tumors), without involvement of the vestibular nerves. NF3 develops in adulthood and is often associated with chronic pain. Dysesthesia and paresthesia may also be present. Common localizations include the spine, peripheral nerves, and the cranium. | The least frequent form of the rare genetic disorder neurofibromatosis. It is clinically and genetically distinct from NF1 and NF2 and is characterized by the development of multiple schwannomas (nerve sheath tumors), without involvement of the vestibular nerves. NF3 develops in adulthood and is often associated with chronic pain. Dysesthesia and paresthesia may also be present. Common localizations include the spine, peripheral nerves, and the cranium. |
MONDO:0015104 | porphyria cutanea tarda | Porphyria cutanea tarda (PCT) is the most common form of chronic hepatic porphyria. It is characterized by bullous photodermatitis. | The most common form of chronic hepatic porphyria. It is characterized by bullous photodermatitis. |
MONDO:0008756 | alopecia - intellectual disability syndrome | Alopecia-intellectual deficit syndrome is an extremely rare syndrome described in less than 20 families to date and characterized by total or partial alopecia associated with intellectual deficit. The syndrome can be associated with other anomalies such as seizures,... |
v2022-07-01
Overview:
- Number of new terms: 100
- Number of changed labels: 17
- Number of changed definitions: 55
- Number obsoleted terms: 15
- Number of new obsoletion candidates: 120
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0024770 | autoinflammatory syndrome, familial, X-linked, Behcet-like 2 | |
MONDO:0024781 | immunodeficiency 102 | |
MONDO:0027652 | 5-fluorouracil toxicity | |
MONDO:0027653 | abacavir toxicity | |
MONDO:0027655 | allopurinol toxicity | |
MONDO:0027664 | cisplatin toxicity | |
MONDO:0027666 | codeine toxicity | |
MONDO:0027667 | efavirenz toxicity | |
MONDO:0027668 | flucloxacilline toxicity | |
MONDO:0027675 | irinotecan toxicity | |
MONDO:0027677 | isoniazid toxicity | |
MONDO:0027687 | raltegravir toxicity | |
MONDO:0027696 | voriconazole toxicity | |
MONDO:0030756 | Stuve-Wiedemann syndrome 2 | |
MONDO:0030770 | congenital disorder of deglycosylation 2 | |
MONDO:0030781 | restrictive dermopathy 2 | |
MONDO:0030881 | developmental and epileptic encephalopathy 102 | |
MONDO:0030886 | holoprosencephaly 14 | |
MONDO:0030887 | cardiomyopathy, dilated, 2G | |
MONDO:0030890 | pontocerebellar hypoplasia, IIA 17 | |
MONDO:0030891 | intellectual developmental disorder, autosomal dominant 66 | |
MONDO:0031213 | restrictive dermopathy | |
MONDO:0031257 | high altitude pulmonary edema | A rare pulmonary condition characterized by non-cardiogenic pulmonary edema occurring in otherwise healthy individuals within days of an ascent above 2500-3000 m. Early symptoms include exertional dyspnea, non-productive cough, chest tightness, and reduced exercise performance, followed by dyspnea at rest and possibly orthopnea, as well as gurgling in the chest and pink frothy sputum in advanced cases. Clinical signs are cyanosis, tachypnea, tachycardia, crackles or wheezing, and elevated body temperature (generally not exceeding 38.5°C). Signs of concomitant high-altitude cerebral edema may also be observed. Chest x-rays typically show patchy opacities predominantly in the right middle lobe. |
MONDO:0031280 | Stuve-Wiedemann syndrome | |
MONDO:0031376 | congenital disorder of deglycosylation | |
MONDO:0031384 | autoinflammatory syndrome, familial, Behcet-like | |
MONDO:0033169 | curariform drugs toxicity | |
MONDO:0033170 | statin toxicity | |
MONDO:0033181 | phenytoin or carbamazepine toxicity | |
MONDO:0033938 | acute radiation syndrome | |
MONDO:0034989 | intellectual disability-cardiac anomalies-short stature-joint laxity syndrome | A rare genetic multiple congenital anomalies/dysmorphic syndrome characterized by intrauterine and postnatal growth restriction, global developmental delay, intellectual disability, and dysmorphic facial features (such as broad nasal root, anteverted nares, long philtrum, low-set and posteriorly rotated ears, and short neck). Additional reported manifestations are microcephaly, short stature, vertebral abnormalities, joint laxity, ocular, cardiac, and renal defects, and minor limb anomalies. Brain imaging may show hypoplastic corpus callosum, delayed myelination, and cerebral atrophy. |
MONDO:0034991 | intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | A rare genetic disease characterized by the presence of multiple café-au-lait macules and elevated rates of sister chromatid exchange demonstrated on cytogenetic testing. Pre- and postnatal growth deficiency with short stature, microcephaly, mild developmental delay, cardiomyopathy, and symptomatic gastro-esophageal reflux have also been described, while malar rash is typically absent. |
MONDO:0035337 | Duane retraction syndrome with congenital deafness | A rare neurologic disease characterized by the presence of Duane retraction syndrome (i. e. a congenital cranial dysinnervation disorder with unilateral or bilateral limitation of abduction and/or adduction of the eye, as well as globe retraction and palpebral fissure narrowing on attempted adduction) in combination with congenital unilateral or bilateral hearing loss. The sidedness of hearing loss corresponds to the sidedness of the retraction syndrome. |
MONDO:0035344 | acute bilirubin encephalopathy | A rare neurologic disease characterized by lethargy, hypotonia, poor feeding, opisthotonus, and a typical high-pitched cry due to bilirubin accumulation in the globus pallidus, sub-thalamic nuclei, and other brain regions, resulting from severe neonatal unconjugated hyperbilirubinemia. Onset of symptoms is typically within the first three to five days of life. Additional features include fever, apnea, seizures, and coma. Especially respiratory failure or refractory seizures may lead to a fatal outcome. |
MONDO:0035345 | chronic bilirubin encephalopathy | A rare neurologic disease characterized by the chronic consequences of bilirubin toxicity in the globus pallidus, sub-thalamic nuclei, and other brain regions, after exposure to high levels of unconjugated bilirubin in the neonatal period. Symptoms begin after the acute phase of bilirubin encephalopathy in the first year of life, evolve slowly over several years, and include mild to severe extrapyramidal disturbances (especially dystonia and athetosis), auditory neuropathy spectrum disorder, and oculomotor and dental abnormalities. |
MONDO:0035350 | letrozole toxicity | |
MONDO:0035763 | idiopathic non-lupus full-house nephropathy | |
MONDO:0035764 | idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance | |
MONDO:0035777 | parenteral nutrition-associated cholestasis | A rare hepatic disease characterized by intrahepatic cholestasis and deterioration of liver function in patients receiving parenteral nutrition for extended periods of time (signs may appear as early as within the first two weeks of initiation of parenteral nutrition). The condition commonly occurs in neonates and usually resolves with transition to enteral feeding, although severe cases may progress to liver fibrosis, cirrhosis, and portal hypertension. |
MONDO:0035838 | idiopathic multicentric Castleman disease | |
MONDO:0035875 | ivermectin toxicity | |
MONDO:0035876 | belinostat toxicity or dose selection | |
MONDO:0035930 | neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency | |
MONDO:0035940 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | |
MONDO:0035941 | B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) | |
MONDO:0035942 | B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) | |
MONDO:0035943 | B-lymphoblastic leukemia/lymphoma with hyperdiploidy | |
MONDO:0035944 | B-lymphoblastic leukemia/lymphoma with hypodiploidy | |
MONDO:0035945 | B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) | |
MONDO:0036025 | toxicity to dolutegravir | |
MONDO:0036042 | KAT6B-related multiple congenital anomalies syndrome | |
MONDO:0036045 | euthyroid dysprealbuminemic hyperthyroxinemia | |
MONDO:0036189 | oculogastrointestinal-neurodevelopmental syndrome | |
MONDO:0036192 | EN1-related dorsoventral syndrome | |
MONDO:0036193 | parkinsonism with polyneuropathy | |
MONDO:0036212 | spastic paraparesis-cataracts-speech delay syndrome | |
MONDO:0036217 | lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due to a point mutation | |
MONDO:0036218 | lethal pontocerebellar hypoplasia-hypotonia-respiratory insufficiency syndrome due to biallelic deletions in the ATAD3 gene cluster | |
MONDO:0037149 | HSD10 disease, atypical type | |
MONDO:0037398 | pneumonia caused by pseudomonas aeruginosa infection | A rare pulmonary disease characterized by primary or nonbacteremic pneumonia most frequently arising in an intensive care setting, or bacteremic pneumonia, which is typically associated with neutropenia. Chronic lower respiratory tract infection with development of episodes of pneumonia is common in patients with cystic fibrosis. Acute infections are potentially life-threatening. Patients present with fever, chills, dyspnea, cyanosis, productive cough, as well as signs of severe systemic toxicity. Alveolar hemorrhage, necrosis, and, eventually, cavity formation, are commonly seen. |
MONDO:0100464 | acid sphingomyelinase deficiency | An autosomal recessive lysosomal disease caused by biallelic loss of function variants in the SMPD1 gene. Clinical symptoms in affected individuals occur along a continuum. At the severe end of the spectrum are individuals historically diagnosed with Niemann-Pick disease type A (the neurovisceral form), which is characterized by hepatosplenomegaly with rapid neurological deterioration leading to death in the first few years of life. At the milder end of the spectrum are individuals historically diagnosed with Niemann-Pick disease type B, a later-onset, chronic visceral form, characterized by progressive visceral organ symptoms including hepatosplenomegaly and pulmonary insufficiency, and survival into adulthood. In addition, some affected individuals present with an intermediate phenotype, Niemann-Pick disease type A/B. |
MONDO:0100465 | complex neurodevelopmental disorder with or without congenital anomalies | A complex neurodevelopmental disorder that involves more than one phenotype associated with the central nervous system, including but not limited to intellectual disability, autism, and seizures (epilepsy), in addition to one or more structural or functional anomaly(ies) that develops prenatally. |
MONDO:0100492 | Bonnevie-Ullrich syndrome | A genetic syndrome which occurs in females. It is caused by the inheritance of only one complete X chromosome (45, X). Clinical signs of the symmetrical form are identical to those of Turner syndrome and include bilateral webbin... |
v2022-06-01
Overview:
- Number of new terms: 29
- Number of changed labels: 4
- Number of changed definitions: 22
- Number obsoleted terms: 16
- Number of new obsoletion candidates: 19
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0024771 | myopathy, distal, 7, adult-onset, X-linked | |
MONDO:0024777 | immunodeficiency 98 with autoinflammation, X-linked | |
MONDO:0030619 | retinitis pigmentosa 92 | |
MONDO:0030669 | gastrointestinal defects and immunodeficiency syndrome 2 | |
MONDO:0030729 | Tessadori-van Haaften neurodevelopmental syndrome 1 | |
MONDO:0030730 | Tessadori-van Haaften neurodevelopmental syndrome 2 | |
MONDO:0030746 | epidermolysis bullosa, junctional 2A, intermediate | |
MONDO:0030747 | epidermolysis bullosa, junctional 2B, severe | |
MONDO:0030748 | epidermolysis bullosa, junctional 3A, intermediate | |
MONDO:0030749 | epidermolysis bullosa, junctional 3B, severe | |
MONDO:0030750 | epidermolysis bullosa, junctional 4, intermediate | |
MONDO:0030768 | epidermolysis bullosa, junctional 5A, intermediate | |
MONDO:0030785 | intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly | |
MONDO:0030787 | spermatogenic failure 71 | |
MONDO:0030797 | retinitis pigmentosa 93 | |
MONDO:0030798 | immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias | |
MONDO:0030800 | cholestasis, progressive familial intrahepatic, 9 | |
MONDO:0030809 | spermatogenic failure 72 | |
MONDO:0030810 | cholestasis, progressive familial intrahepatic, 10 | |
MONDO:0030813 | immunodeficiency 101 (varicella zoster virus-specific) | |
MONDO:0030815 | cholestasis, progressive familial intrahepatic, 11 | |
MONDO:0030818 | spermatogenic failure 73 | |
MONDO:0030819 | meckel syndrome 14 | |
MONDO:0030822 | renal hypodysplasia/aplasia 4 | |
MONDO:0100460 | tobacco addiction, susceptibility to | An inherited susceptibility or predisposition to developing nicotine dependence. |
MONDO:0100463 | methylmalonic aciduria and/or homocystinuria, cblD type | An autosomal recessive inborn disorder of cobalamin metabolism caused by biallelic variants in MMADHC. Depending on the type and location of variants in MMADHC, patients may present with methylmalonic aciduria, homocystinuria, or both. MMADHC has been reported to result in the cblD complementation group of cobalamin disorders. |
MONDO:0700073 | glutaric acidemia IIa | Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFA gene. |
MONDO:0700074 | glutaric acidemia IIb | Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFB gene. |
MONDO:0700076 | glutaric acidemia IIc | Any multiple acyl-CoA dehydrogenase deficiency in which the cause of the disease is a mutation in the ETFDH gene. |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0007818 | hyper-IgE recurrent infection syndrome 1 | Hyper-IgE recurrent infection syndrome 1 | hyper-IgE recurrent infection syndrome 1 |
MONDO:0008675 | Freeman-Sheldon syndrome | freeman-Sheldon syndrome | Freeman-Sheldon syndrome |
MONDO:0014977 | autosomal recessive limb-girdle muscular dystrophy type 2R1 | autosomal recessive limb-girdle muscular dystrophy type 2Z | autosomal recessive limb-girdle muscular dystrophy type 2R1 |
MONDO:0044640 | Charcot-Marie-Tooth disease type 2T | charcot-marie-tooth disease type 2T | Charcot-Marie-Tooth disease type 2T |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0000188 | GLUT1 deficiency syndrome | An epileptic encephalopathy resulting from impaired glucose transport into the brain. | |
MONDO:0002279 | iron metabolism disease | Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed) | Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. |
MONDO:0001793 | excessive tearing | Diseases of the lacrimal apparatus. | Profuse lacrimation. |
MONDO:0016085 | Cole-Carpenter syndrome | Cole-Carpenter syndrome is an extremely rare form of bone dysplasia characterized by the features of osteogenesis imperfecta such as bone fragility associated with multiple fractures, bone deformities (metaphyseal irregularities and bowing of the long bones) and blue sclera, in association with growth failure, craniosynostosis, hydrocephalus, ocular proptosis, and distinctive facial features (e.g. frontal bossing, midface hypoplasia, and micrognathia). | An extremely rare form of bone dysplasia characterized by the features of osteogenesis imperfecta such as bone fragility associated with multiple fractures, bone deformities (metaphyseal irregularities and bowing of the long bones) and blue sclera, in association with growth failure, craniosynostosis, hydrocephalus, ocular proptosis, and distinctive facial features (e.g. frontal bossing, midface hypoplasia, and micrognathia). |
MONDO:0007252 | Gordon syndrome | Gordon syndrome, also known as distal arthrogryposis type 3, is an extremely rare multiple congenital malformation syndrome characterized by congenital contractures of hand and feet with variable degrees of severity of camptodactyly, clubfoot and, less frequently, cleft palate. Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present. Gordon syndrome, Marden-Walker syndrome and arthrogryposis with oculomotor limitation and electroretinal anomalies clinically and genetically overlap, and could represent variable expressions of the same condition. | An extremely rare multiple congenital malformation syndrome characterized by congenital contractures of hand and feet with variable degrees of severity of camptodactyly, clubfoot and, less frequently, cleft palate. Intelligence is normal but in some cases, additional abnormalities, such as short stature, kyphoscoliosis, ptosis, micrognathia, and cryptorchidism may also be present. Gordon syndrome, Marden-Walker syndrome and arthrogryposis with oculomotor limitation and electroretinal anomalies clinically and genetically overlap, and could represent variable expressions of the same condition. |
MONDO:0019162 | pseudohypoaldosteronism type 2 | Pseudohypoaldosteronism type 2 (PHA2) is a rare inherited form of hypertension characterized by hyperkalemia, hyperchloremic metabolic acidosis, normal or elevated aldosterone, low renin, and normal renal function. | A rare inherited form of hypertension characterized by hyperkalemia, hyperchloremic metabolic acidosis, normal or elevated aldosterone, low renin, and normal renal function. |
MONDO:0007827 | inclusion body myositis | Inclusion body myositis (IBM) is a slowly progressive degenerative inflammatory disorder of skeletal muscles characterized by late onset weakness of specific muscles and distinctive histopathological features. | A slowly progressive degenerative inflammatory disorder of skeletal muscles characterized by late onset weakness of specific muscles and distinctive histopathological features. |
MONDO:0016797 | multiple mitochondrial DNA deletion syndrome | A mitochondrial oxidative phosphorylation disorder in which mitochondrial DNA (mtDNA) level is lower than normal. | |
MONDO:0018975 | neurofibromatosis type 1 | Neurofibromatosis type 1 (NF1) is a clinically heterogeneous, neurocutaneous genetic disorder characterized by cafe-au-lait spots, iris Lisch nodules, axillary and inguinal freckling, and multiple neurofibromas. | A clinically heterogeneous, neurocutaneous genetic disorder characterized by cafe-au-lait spots, iris Lisch nodules, axillary and inguinal freckling, and multiple neurofibromas. |
MONDO:0019027 | otopalatodigital syndrome | Otopalatodigital (OPD) syndrome is a form of frontootopalatodigital syndrome, characterized by deafness, cleft palate, and characteristic digital anomalies. OPD syndrome is divided into two forms based on severity: the milder form designated OPD type 1 (OPD1), and the more severe and often lethal form designated OPD type 2 (OPD2). OPD is an X-linked disorder. Two other genetic disorders with features overlapping OPD, frontometaphyseal dysplasia (FMD) and osteodysplasty, Melnick-Needles type (MNS) have been described; thus OPD1, OPD2, FMD, and MNS are allelic disorders. | A form of frontootopalatodigital syndrome, characterized by deafness, cleft palate, and characteristic digital anomalies. OPD syndrome is divided into two forms based on severity: the milder form designated OPD type 1 (OPD1), and the more severe and often lethal form designated OPD type 2 (OPD2). OPD is an X-linked disorder. Two other genetic disorders with features overlapping OPD, frontometaphyseal dysplasia (FMD) and osteodysplasty, Melnick-Needles type (MNS) have been described; thus OPD1, OPD2, FMD, and MNS are allelic disorders. |
MONDO:0010704 | otopalatodigital syndrome type 1 | Otopalatodigital syndrome type 1 (OPD1) is the mildest form of otopalatodigital syndrome spectrum disorder, and is characterized by a generalized skeletal dysplasia, mild intellectual disability, conductive hearing loss, and typical facial anomalies. | The mildest form of otopalatodigital syndrome spectrum disorder that is characterized by a generalized skeletal dysplasia, mild intellectual disability, conductive hearing loss, and typical facial anomalies. |
MONDO:0019037 | progressive supranuclear palsy | Progressive supranuclear palsy (PSP) is a rare late-onset neurodegenerative disease characterized by... |
v2022-05-02
Overview:
- Number of new terms: 391
- Number of changed labels: 24
- Number of changed definitions: 13
- Number obsoleted terms: 47
- Number of new obsoletion candidates: 35
- Number of terms who were previously candidate for obsoletion and are now not anymore: 0
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0000140 | obsolete MONDO:0000140 | |
MONDO:0000528 | obsolete MONDO:0000528 | |
MONDO:0000529 | obsolete MONDO:0000529 | |
MONDO:0000559 | obsolete MONDO:0000559 | |
MONDO:0000575 | obsolete MONDO:0000575 | |
MONDO:0000817 | obsolete MONDO:0000817 | |
MONDO:0000821 | obsolete MONDO:0000821 | |
MONDO:0000823 | obsolete MONDO:0000823 | |
MONDO:0000842 | obsolete MONDO:0000842 | |
MONDO:0000843 | obsolete MONDO:0000843 | |
MONDO:0000915 | obsolete MONDO:0000915 | |
MONDO:0001201 | obsolete MONDO:0001201 | |
MONDO:0001605 | obsolete MONDO:0001605 | |
MONDO:0001659 | obsolete MONDO:0001659 | |
MONDO:0002733 | obsolete MONDO:0002733 | |
MONDO:0002773 | obsolete MONDO:0002773 | |
MONDO:0002780 | obsolete MONDO:0002780 | |
MONDO:0003323 | obsolete MONDO:0003323 | |
MONDO:0003576 | obsolete MONDO:0003576 | |
MONDO:0003597 | obsolete MONDO:0003597 | |
MONDO:0003625 | obsolete MONDO:0003625 | |
MONDO:0003986 | obsolete MONDO:0003986 | |
MONDO:0004036 | obsolete MONDO:0004036 | |
MONDO:0004137 | obsolete MONDO:0004137 | |
MONDO:0004347 | obsolete MONDO:0004347 | |
MONDO:0004915 | obsolete MONDO:0004915 | |
MONDO:0004916 | obsolete MONDO:0004916 | |
MONDO:0005274 | obsolete MONDO:0005274 | |
MONDO:0005332 | obsolete MONDO:0005332 | |
MONDO:0005681 | obsolete MONDO:0005681 | |
MONDO:0005713 | obsolete MONDO:0005713 | |
MONDO:0005860 | obsolete MONDO:0005860 | |
MONDO:0006023 | obsolete MONDO:0006023 | |
MONDO:0006707 | obsolete MONDO:0006707 | |
MONDO:0006885 | obsolete MONDO:0006885 | |
MONDO:0014188 | obsolete MONDO:0014188 | |
MONDO:0014913 | obsolete MONDO:0014913 | |
MONDO:0020758 | obsolete MONDO:0020758 | |
MONDO:0021307 | obsolete MONDO:0021307 | |
MONDO:0021690 | obsolete congenital left ventricular aneurysm | OBSOLETE. A rare congenital non-syndromic heart malformation characterized by a bulging of the left ventricular wall, connected to the left ventricle by a wide neck (with a ratio of the connection to the body of the anomaly >1). The dimensions of described aneurysms range from 0.5 cm in diameter up to a size of 8x9 cm. Most frequent locations are the left ventricular apex and the perivalvular area. Aneurysms can be a- or dyskinetic or show almost normal contractility. Patients may remain asymptomatic or present with systemic embolization, congestive heart failure, valvular regurgitation, ventricular wall rupture, ventricular tachycardia, or sudden cardiac death. [Orphanet:1055] |
MONDO:0023539 | obsolete MONDO:0023539 | |
MONDO:0024145 | obsolete Pierre Robin syndrome associated with collagen disease | |
MONDO:0024147 | obsolete Pierre Robin syndrome associated with a chromosomal anomaly | |
MONDO:0024148 | obsolete Pierre Robin syndrome associated with branchial archs anomalies | |
MONDO:0024149 | obsolete Pierre Robin syndrome associated with bone disease | |
MONDO:0024581 | obsolete MONDO:0024581 | |
MONDO:0024772 | intellectual developmental disorder, X-linked, syndromic, Pilorge type | |
MONDO:0024773 | spermatogenic failure, x-linked, 4 | |
MONDO:0024812 | obsolete MONDO:0024812 | |
MONDO:0024987 | obsolete genetic urogenital tract malformation | |
MONDO:0026141 | obsolete genetic urticaria | |
MONDO:0026150 | obsolete genetic erythrokeratoderma | |
MONDO:0026151 | obsolete genetic acrokeratoderma | |
MONDO:0026152 | obsolete genetic porokeratosis | |
MONDO:0026157 | obsolete genetic pigmentation anomaly of the skin | |
MONDO:0026160 | obsolete genetic dermis disorder | |
MONDO:0026166 | obsolete genetic immune deficiency with skin involvement | |
MONDO:0026167 | obsolete genetic neuromuscular disease | |
MONDO:0026170 | obsolete genetic central nervous system malformation | |
MONDO:0026173 | obsolete rare genetic medullar disease | |
MONDO:0026180 | obsolete genetic congenital limb malformation | |
MONDO:0026181 | obsolete genetic renal or urinary tract malformation | |
MONDO:0026182 | obsolete genetic cranial malformation | |
MONDO:0026183 | obsolete genetic digestive tract malformation | |
MONDO:0026184 | obsolete genetic visceral malformation of the liver, biliary tract, pancreas or spleen | |
MONDO:0026185 | obsolete genetic respiratory or mediastinal malformation | |
MONDO:0026186 | obsolete genetic developmental defect of the eye | |
MONDO:0026187 | obsolete genetic malformation syndrome with short stature | |
MONDO:0026188 | obsolete genetic overgrowth/obesity syndrome | |
MONDO:0026189 | obsolete genetic branchial arch or oral-acral syndrome | |
MONDO:0026190 | obsolete genetic malformation syndrome with odontal and/or periodontal component | |
MONDO:0026192 | obsolete genetic glomerular disease | |
MONDO:0026193 | obsolete genetic thrombotic microangiopathy | |
MONDO:0026203 | obsolete genetic respiratory malformation | |
MONDO:0026209 | obsolete genetic polyendocrinopathy | |
MONDO:0026419 | obsolete isolated corpus callosum agenesis | OBSOLETE. A rare non-syndromic cerebral malformation characterized by congenital partial or complete absence of the corpus callosum. Patients are often asymptomatic but may also present with intellectual disability, visual impairment, delayed speech development, seizures, feeding difficulties, impaired hand-eye coordination, and behavioral abnormalities. Patients may have a normal intelligence quotient while exhibiting specific cognitive deficits, such as reduced interhemispheric transfer of sensorimotor information, reduced cognitive processing speed, and deficits in complex reasoning and novel problem-solving. [Orphanet:200] |
MONDO:0026989 | obsolete syndrome associated with hypertrophic cardiomyopathy | |
MONDO:0027929 | obsolete genetic polycythemia | |
MONDO:0028569 | obsolete genetic interstitial lung disease | |
MONDO:0028795 | obsolete rare genetic systemic or rheumatologic disease | |
MONDO:0028868 | obsolete genetic frontotemporal degeneration with dementia | |
MONDO:0029014 | obsolete rare systemic or rheumatological disease of childhood | |
MONDO:0029051 | obsolete autosomal recessive nail dysplasia | OBSOLETE. Autosomal recessive nail dysplasia is a rare, isolated nail anomaly characterized by claw-shaped, thick, hyperplastic, hard and hyperpigmented nails, subungual hyperkeratosis, onycholysis and slow nail growth. Variable degree of disease severity has been reported. [Orphanet:280654] |
MONDO:0029102 | obsolete autosomal ichthyosis syndrome with other associated signs | |
MONDO:0029810 | obsolete laminopathy with striated muscle involvement | |
MONDO:0029811 | obsolete laminopathy with peripheral neuropathy | |
MONDO:0029812 | obsolete laminopathy with lipodystrophy | |
MONDO:0029813 | obsolete laminopathy with premature aging | |
MONDO:0030016 | obsolete MONDO:0030016 | |
MONDO:0030052 | obsolete disease with punctate palmoplantar keratoderma as a major feature | |
MONDO:0030407 | obsolete rare disease with Cushing syndrome as a major feature | |
MONDO:0030537 | central hypoventilation syndrome, congenital, 2, and autonomic dysfunction | |
MONDO:0030539 | central hypoventilation syndrome, congenital, 3 | |
MONDO:0030549 | hearing loss, autosomal dominant 81 | |
MONDO:0030608 | interstitial lung disease 1 | |
MONDO:0030625 | dyskinesia with orofacial involvement, autosomal recessive | |
MONDO:0030634 | leukoencephalopathy, hereditary diffuse, with spheroids 2 | |
MONDO:0030639 | Teebi hypertelorism syndrome | |
MONDO:0030673 | spastic paraplegia 86, autosomal recessive | |
MONDO:0030674 | Teebi hypertelorism syndrome 2 | |
MONDO:0030676 | parkinsonism-dystonia 3, childhood-onset | |
MONDO:0030677 | Charcot-Marie-Tooth disease, demyelinating, IIA 1I | |
MONDO:0030679 | Noonan syndrome 14 | |
MONDO:0030680 | cardiomyopathy, dilated, 2F | |
MONDO:0030681 | immunodeficiency 94 with autoinflammation and dysmorphic facies | |
MONDO:0030684 | hypogonadotropic hypogonadism 27 without anosmia | |
MONDO:0030689 | Charcot-Marie-Tooth disease, demyelinating, IIA 1H | |
MONDO:0030690 | pulmonary fibrosis and/or bone marrow failure, telomere-related, 6 | |
MONDO:0030692 | immunodeficiency 95 | |
MONDO:0030693 | immunodeficiency 96 | |
MONDO:0030695 | developmental and epileptic encephalopathy 100 | |
MONDO:0030696 | mitochondrial DNA depletion syndrome 20 (mngie type) | |
MONDO:0030697 | myopia 28, autosomal recessive | |
MONDO:0030711 | anemia, congenital dyserythropoietic, IIA IIIB, autosomal recessive | |
MONDO:0030712 | oculopharyngodistal myopathy 4 | |
MONDO:0030714 | osteogenesis imperfecta, IIA 22 | |
MONDO:0030716 | spermatogenic failure 66 | |
MONDO:0030717 | immunodeficiency 97 with autoinflammation | |
MONDO:0030718 | spermatogenic failure 67 | |
MONDO:0030719 | deafness, autosomal dominant 82 | |
MONDO:0030721 | spermatogenic failure 68 | |
MONDO:0030723 | hearing loss, autosomal dominant 83 | |
MONDO:0030724 | hearing loss, autosomal dominant 84 | |
MONDO:0030726 | neutropenia, severe congenital, 9, autosomal dominant | |
MONDO:0030727 | developmental and epileptic encephalopathy 101 | |
MONDO:0030731 | aortic aneurysm, familial thoracic 12 | |
MONDO:0030732 | spermatogenic failure 69 | |
MONDO:0030733 | spermatogenic failure 70 | |
MONDO:0030736 | ovarian dysgenesis 10 | |
MONDO:0030767 | obsolete genetic tumor of hematopoietic and lymphoid tissues | |
MONDO:0030796 | leukoencephalopathy, hereditary diffus... |
v2022-04-04
Overview:
- Number of new terms: 13
- Number of changed labels: 8
- Number of changed definitions: 4
- Number obsoleted terms: 73
- Number of new obsoletion candidates: 16
- Number of terms who were previously candidate for obsoletion and are now not anymore: 1
New terms
Mondo ID | Label | Definition |
---|---|---|
MONDO:0100487 | TPM4-related platelet disorder | A platelet disorder in which the cause of the disease is a variant in the TPM4 gene. |
MONDO:0100488 | CDH1-related diffuse gastric and lobular breast cancer | Germline pathogenic or likely pathogenic variants in the CDH1 gene predispose to hereditary diffuse gastric cancer, a cancer susceptibility syndrome inherited in an autosomal dominant pattern, initially characterized by the increased risk for diffuse gastric cancer (DGC) but subsequently well documented to be associated with lobular breast cancer (LBC) in women. |
MONDO:0100489 | Graves disease, susceptibility to, 1 | |
MONDO:0100490 | breasts and/or nipples, aplasia or hypoplasia of, 1 | |
MONDO:0100491 | generalized pustular psoriasis | A rare and extreme form of psoriasis characterized by the appearance of sterile pustules which can take many patterns. All the main pathological features of the disease are accentuated. Generalized pustular psoriasis is clinically heterogeneous in its age at onset, precipitants, severity, and natural history. Many overlapping clinical entities are recognized. There is a relationship between these entities and plaque psoriasis, as some individuals may have episodes of plaque psoriasis preceding or following the generalized pustular psoriasis, but in others generalized pustular psoriasis occurs as the sole phenotype without plaque psoriasis at any time. |
MONDO:0700043 | syndrome caused by partial chromosomal duplication of the short arm of chromosome 9 | |
MONDO:8000023 | type 3 autoimmune lymphoproliferative syndrome | A rare, primary immunodeficiency. It is caused by a currently undetermined defect in the Fas-induced apoptosis pathway. No mutations in Fas, FASLG or CASP10 are detectable. Disruption of Fas-induced apoptosis impairs lymphocyte homeostasis and immune tolerance. Characteristic laboratory findings include an increase in circulating, double-negative (CD4-/CD8-) T cells in the setting of immune-mediated anemia, thrombocytopenia and neutropenia. Clinical signs present in childhood include fatigue, pallor, bruising, hepatosplenomegaly and chronic, non-malignant, non-infectious lymphadenopathy. The clinical course is influenced by a strong association with other autoimmune disorders and an increased risk for developing Hodgkin and non-Hodgkin lymphoma. |
MONDO:8000024 | autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD | Any autoimmune lymphoproliferative syndrome in which the cause of the disease is a mutation in the PRKCD gene. |
MONDO:8000030 | obsolete morphological anomaly | |
MONDO:8000031 | obsolete subtype of a disorder | |
MONDO:8000032 | obsolete malformation syndrome | |
MONDO:8000033 | obsolete group of disorders | |
MONDO:8000034 | obsolete disorder |
Changed terms
Changed labels
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0003778 | inborn errors of immunity | primary immunodeficiency disease | inborn errors of immunity |
MONDO:0008791 | anencephaly 1 | isolated anencephaly/exencephaly | anencephaly 1 |
MONDO:0013612 | geleophysic dysplasia 2 | Geleophysic dysplasia 2 | geleophysic dysplasia 2 |
MONDO:0014320 | Bosch-Boonstra-Schaaf optic atrophy syndrome | optic atrophy-intellectual disability syndrome | Bosch-Boonstra-Schaaf optic atrophy syndrome |
MONDO:0018983 | Tolosa-Hunt syndrome | tolosa-Hunt syndrome | Tolosa-Hunt syndrome |
MONDO:0020745 | ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome | autosomal dominant cardiac arrhythmia (Kuhn) | ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome |
MONDO:0043195 | Rubinstein Taybi like syndrome | rubinstein taybi like syndrome | Rubinstein Taybi like syndrome |
MONDO:0700130 | partial trisomy 21 | partial Trisomy 21 | partial trisomy 21 |
Changed definitions
Mondo ID | Label | Previous release | New release |
---|---|---|---|
MONDO:0006086 | angiomyxoma | A benign soft tissue neoplasm characterized by the presence of neoplastic spindle and stellate cells in a myxoid stroma. | A benign soft tissue neoplasm characterized by the presence of neoplastic spindle and stellate cells, and vascular proliferation in a myxoid stroma. |
MONDO:0700085 | pentasomy | A chromosomal anomaly consisting of the presence of three chromosomes of the same type in addition to the normal diploid number. | A chromosomal disorder consisting of the presence of three chromosomes of the same type in addition to the normal diploid number. |
MONDO:0017388 | celiac trunk compression syndrome | A rare disease caused by compression of the celiac axis by an abnormally shaped arcuate ligament (the part of the diaphragm in which both pillars join in the midline around the aorta). Patients have recurrent abdominal pain, anorexia and weight loss. The pain is epigastric, and diarrhea or constipation may be present as well. Onset of pain will usually, although not always, be after food intake, and may be associated with nausea and emesis. Other symptoms may include lassitude, exercise intolerance and vomiting. Occasionally, a patient may show an abdominal murmur upon auscultation. | |
MONDO:0030502 | tetrasomy | A chromosomal anomaly consisting of the presence of two chromosomes of the same type in addition to the normal diploid number. | A chromosomal disorder consisting of the presence of two chromosomes of the same type in addition to the normal diploid number. |
Obsolete terms
Mondo ID | Label |
---|---|
MONDO:0000651 | obsolete thoracic disorder |
MONDO:0006588 | obsolete nonepidermolytic palmoplantar keratoderma |
MONDO:0007139 | obsolete Antipyrine metabolism |
MONDO:0007141 | obsolete antiviral state repressor, regulator of |
MONDO:0007317 | obsolete chlorpropamide-alcohol flushing |
MONDO:0007331 | obsolete cleft chin |
MONDO:0007532 | obsolete Electroencephalographic peculiarity: occipital slow beta waves |
MONDO:0007591 | obsolete facial hypertrichosis |
MONDO:0007622 | obsolete flood factor deficiency |
MONDO:0007645 | obsolete gastric sneezing |
MONDO:0007692 | obsolete hairy ears |
MONDO:0007822 | obsolete incisors, long upper central |
MONDO:0007823 | obsolete insulin receptors, familial increase 1N |
MONDO:0008068 | obsolete navicular bone, accessory |
MONDO:0008110 | obsolete ocular dominance |
MONDO:0008326 | obsolete pseudocholinesterase, increase in plasma level of |
MONDO:0008351 | obsolete pupil, egg-shaped |
MONDO:0008405 | obsolete scapula, contour of vertebral border of |
MONDO:0008432 | obsolete ketone compounds, ability to smell |
MONDO:0008548 | obsolete theophylline Biotransformation |
MONDO:0008616 | obsolete twinning due to superfetation |
MONDO:0008625 | obsolete urate-binding globulin, decrease 1N |
MONDO:0008677 | obsolete widow's peak |
MONDO:0009125 | obsolete dopamine beta-hydroxylase, plasma, thermolability of |
MONDO:0009250 | obsolete fructose utilization |
MONDO:0009553 | obsolete Plasmodium falciparum blood infection level |
MONDO:0009829 | obsolete pallidal degeneration, progressive, with retinitis pigmentosa |
MONDO:0009930 | obsolete pulmonary arteriovenous malformation |
MONDO:0010705 | obsolete ouabain resistance |
MONDO:0010994 | obsolete micromelic dwarfism, Fryns type |
MONDO:0011554 | obsolete deafness, nonsyndromic, modifier 1 |
MONDO:0011692 | obsolete basal ganglia calcification, idiopathic, 2 |
MONDO:0013538 | obsolete alpha-2-macroglobulin deficiency |
MONDO:0013586 | obsolete Chitotriosidase deficiency |
MONDO:0013799 | obsolete efavirenz, poor metabolism of |
MONDO:0014053 | obsolete stomatin-like protein-2, hyperphosphorylation of |
MONDO:0014253 | obsolete autoimmune lymphoproliferative syndrome type 3 |
MONDO:0014826 | obsolete nucleoside diphosphate-linked moiety X Motif 15 deficiency |
MONDO:0015153 | obsolete autosomal monosomy |
MONDO:0016946 | obsolete partial trisomy of the short arm of chromosome 9 |
MONDO:0016962 | obsolete partial duplication of the long arm of chromosome 11 |
MONDO:0016963 | obsolete partial duplication of the long arm of chromosome 13 |
MONDO:0016998 | obsolete complex chromosomal rearrangement |
MONDO:0016999 | obsolete X chromosome number anomaly |
MONDO:0017002 | obsolete polysomy of X chromosome |
MONDO:0017005 | obsolete Y chromosome number anomaly |
MONDO:0017006 | obsolete X and Y chromosomal anomaly |
MONDO:0017011 | obsolete uniparental disomy of chromosome X |
MONDO:0017412 | obsolete 2q31.1 microduplication syndrome |
MONDO:0018186 | obsolete ring chromosome |
MONDO:0019683 | obsolete syndactyly type 2 |
MONDO:0020050 | obsolete autosomal trisomy |
MONDO:0020053 | obsolete total autosomal monosomy |
MONDO:0020054 | obsolete partial autosomal monosomy |
MONDO:0020055 | obsolete autosomal uniparental disomy |
MONDO:0020056 | obsolete uniparental disomy of maternal origin |
MONDO:0020057 | obsolete uniparental disomy of paternal origin |
MONDO:0020059 | obsolete gonosome number anomaly |
MONDO:0020060 | obsolete gonosome structural anomaly |
MONDO:0020061 | obsolete chromosome Y structural anomaly |
MONDO:0020062 | obsolete chromosome X structural anomaly |
MONDO:0020734 | obsolete erythrocyte AMP deaminase deficiency |
MONDO:0021059 | obsolete head or neck disorder/disorder |
MONDO:0022109 | obsolete catatrichy |
MONDO:0022794 | obso... |